AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 529729: Dimethyl 1,3,3,3-tetrachloro-2-oxopropylmalonate

Chemical compound data from PubChem database. IUPAC Name: dimethyl 2-(1,3,3,3-tetrachloro-2-oxopropyl)propanedioate. Molecular Formula: C8H8Cl4O5. Molecular Weight: 326.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530395: 2,3,3-Trimethyl-1-hexene

Chemical compound data from PubChem database. IUPAC Name: 2,3,3-trimethylhex-1-ene. Molecular Formula: C9H18. Molecular Weight: 126.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530611: 3-Cyclopentylpropionic acid, hex-4-yn-3-yl ester

Chemical compound data from PubChem database. IUPAC Name: hex-4-yn-3-yl 3-cyclopentylpropanoate. Molecular Formula: C14H22O2. Molecular Weight: 222.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401744-T1: [Translated] METHOD FOR CODING MOVING IMAGES AND METHOD FOR DECODING MOVING IMAGES

A moving picture coding apparatus includes a motion estimation unit (101) for performing motion estimation by fixing the one of two reference pictures as a reference picture indicated by an inputted default reference picture number DefRefNo and a variable length coding unit (107) for performing variable length coding on coded residual data ERes, a prediction type PredType, a reference picture number RefNo2 and motion vectors MV1, MV2 on a block-by-block basis, and outputting them as coded moving picture data Str.
Compound 525793: N-(3-Methoxyphenyl)-N'-(3-ethoxyphenyl)formamidine

Chemical compound data from PubChem database. IUPAC Name: N-(3-ethoxyphenyl)-N'-(3-methoxyphenyl)methanimidamide. Molecular Formula: C16H18N2O2. Molecular Weight: 270.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
AFCARS Report #20

This report provides preliminary estimates of AFCARS data for FY 2012. Preliminary reports of AFCARS data include data received by September 30 for the report period ending March 31 and by March 31 for the report period ending September 30. This generally encompasses the required data submissions and submission of corrected data by States to avoid possible financial penalties.

Metadata-only record linking to the original dataset. Open original dataset below.
Department of Child Support Services Case Overview FFY 2015 - FFY 2023

This data table provides the basic information for California child support cases, such as number of cases per county, the number of cases where the child is currently receiving public assistance, number of cases where the child formerly received public assistance (but no longer does), and the number of cases where the child has never received public assistance.  The data is sorted by county and broken into the Current Public Assistance, Former Public Assistance and Never Assisted types, the table will also show the percentage of that county’s total caseload.
Compound 525362: 2,3-Dimethyl-4,5-dithiahexane

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-3-(methyldisulfanyl)butane. Molecular Formula: C6H14S2. Molecular Weight: 150.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension In Pregnancy 2 (

Background
          Uncertainty remains about the potential harmful effects of antihypertensive therapy on the developing fetus, especially for beta-blockers (βb).
        
        
          Methods
          We prospectively enrolled all singleton women with a blood pressure ≥ 140/90 mm Hg during pregnancy. The main analysis included 1948 women with all forms of hypertension and compared the use of βb drugs, non-βb drugs or a combination of both, to no treatment. The primary study outcome was a composite of the diseases of prematurity, need for assisted ventilation for greater than 1 day, or perinatal death. A sub-group analysis evaluated the four treatment options among 583 singleton women with chronic hypertension before 20 weeks gestation.
        
        
          Results
          In the main analysis, no association was observed between βb use and the primary composite outcome [adjusted odds ratio (OR) 1.4, 95% CI 0.9–2.2], while an association was seen with non-βb therapy (OR 5.0, 95% CI 2.6–9.6) and combination therapy (OR 2.9, 95% CI 1.8–4.7). In the sub-group of 583 women with hypertension before 20 weeks, use of a non-βb drug (OR 4.9, 95% CI 1.7–14.2) or combination therapy (OR 2.9. 95% CI 1.1–7.7) was significantly associated with the primary composite outcome, while βb monotherapy was not (OR 1.4, 95% CI 0.6–3.4).
        
        
          Conclusions
          Maternal use of antihypertensive medications other than βbs was associated with both major perinatal morbidity and mortality, while βb monotherapy was not. The combined use of βb and non-βb medications demonstrated the strongest association. Before definitive conclusions can be drawn, a large multicentre randomized controlled trial is needed to address the issues of both maternal efficacy and fetal safety with the use of one or more antihypertensive agents in pregnancy.
Compound 526397: 2,7-Dibromo,1,9-dichloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 2,7-dibromo-1,9-dichlorodibenzo-p-dioxin. Molecular Formula: C12H4Br2Cl2O2. Molecular Weight: 410.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Doxercalciferol

Doxercalciferol is a prescription medication available as oral capsules in strengths of 0.5 mcg, 1 mcg, and 2.5 mcg. It is a vitamin D2 analog used to help regulate calcium and phosphorus levels in the body, particularly for patients with certain kidney conditions. Manufactured by Heritage Pharmaceuticals and Chartwell RX, LLC, this generic drug is approved under ANDA 205360. This information was generated using AI and is provided for informational and research purposes only.
2018 Mental Health Client-level Data (MH-CLD) Annual Report

This report presents results from the Mental Health Client-Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health services from state mental health systems in 2018, as well as selected trends in data collected from such individuals between 2013 and 2018. The report provides information on mental health diagnoses, mental health treatment settings, and demographic and substance use characteristics of individuals in mental health treatment in facilities that reported to individual state administrative data systems.
Compound 528344: Benzoic acid, 5-chloro-2-hydroxy, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 5-chloro-2-trimethylsilyloxybenzoate. Molecular Formula: C13H21ClO3Si2. Molecular Weight: 316.92. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527558: 1,3-Cyclohexadiene, 6-iodo

Chemical compound data from PubChem database. IUPAC Name: 5-iodocyclohexa-1,3-diene. Molecular Formula: C6H7I. Molecular Weight: 206.02. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527555: 1,3-Cyclohexadiene, 5-iodo-6-methyl

Chemical compound data from PubChem database. IUPAC Name: 5-iodo-6-methylcyclohexa-1,3-diene. Molecular Formula: C7H9I. Molecular Weight: 220.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399686-T1: [Translated] LOCKING DEVICE FOR A STEERING SPINDLE

The device has a bolt comprising housings intended to cooperate with contiguous movable bodies (4, 4`). A finger (8) unblocks and frees the bodies, and automatically houses one of the bodies in one of the housings when the bolt is in position of blocking of a steering column. The housings are situated on both side of a median line, virtually delimiting a face of a small side of the bolt.
San Francisco – SF Div: Drug-Related Emergency Department Visits, 2004-2011 - Underage Drinking

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving underage drinking in the San Francisco division of the San Francisco metropolitan area, covering 2004-2011.  Underage drinking includes ED visits that involve alcohol use (alone or with other drugs) for patients under the age of 21.
Compound 530511: 2-Chlorobenzoic acid, 1-adamantylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: 1-adamantylmethyl 2-chlorobenzoate. Molecular Formula: C18H21ClO2. Molecular Weight: 304.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2011 CMHS Uniform Reporting System (URS) Output Tables for Kentucky

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis

Purpose
          A systematic review of the literature was carried out to determine the role of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) .
        
        
          Methods
          To be eligible, full published trials needed to deal with SCLC and to have randomly assigned patients to receive PCI or not. Trials quality was assessed by two scores (Chalmers and ELCWP).
        
        
          Results
          Twelve randomised trials (1547 patients) were found to be eligible. Five evaluated the role of PCI in SCLC patients who had complete response (CR) after chemotherapy. Brain CT scan was done in the work-up in five studies and brain scintigraphy in six. Chalmers and ELCWP scores are well correlated (p < 0.001), with respective median scores of 32.6 and 38.8 %. This meta-analysis based on the available published data reveals a decrease of brain metastases incidence (hazard ratio (HR): 0.48; 95 % confidence interval (CI): 0.39 - 0.60) for all the studies and an improvement of survival (HR: 0.82; 95 % CI: 0.71 - 0.96) in patients in CR in favour of the PCI arm. Unfortunately, long-term neurotoxicity was not adequately described .
        
        
          Conclusions
          PCI decreases brain metastases incidence and improves survival in CR SCLC patients but these effects were obtained in patients who had no systematic neuropsychological and brain imagery assessments. The long-term toxicity has not been prospectively evaluated. If PCI can be recommended in patients with SCLC and CR documented by a work-up including brain CT scan, data are lacking to generalise its use to any CR situations.
Compound 530133: 7-Methylguanine, TMS

Chemical compound data from PubChem database. IUPAC Name: 9-methyl-N-trimethylsilyl-6-trimethylsilyloxypurin-2-amine. Molecular Formula: C12H23N5OSi2. Molecular Weight: 309.51. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Blood substitutes Artificial oxygen carriers: perfluorocarbon		  emulsions

Perfluorocarbon emulsions are being clinically evaluated as			 artificial oxygen carriers to reduce allogeneic blood transfusions or to			 improve tissue oxygenation. Perfluorocarbon emulsions are efficacious in animal			 experiments, and in humans they are well tolerated and at least as successful			 to reverse physiologic transfusion triggers than autologous blood.			 Perfluorocarbon emulsions may be used in the future in the concept of augmented			 acute normovolaemic haemodilution. In this concept relatively low preoperative			 haemoglobin levels are targeted during preoperative normovolaemic haemodilution			 and a perfluorocarbon emulsion is given to augment oxygen delivery during			 surgery when low endogenous haemoglobin levels are expected. The autologous			 blood is subsequently retransfused in the postoperative period when the			 patient's oxygenation is provided primarily by the endogenous			 haemoglobin. Additional uses of perfluorocarbon emulsions will include			 treatments of diseases with compromised tissue oxygenation such as cerebral or			 myocardial ischaemia, air embolism and emergency or trauma surgery as long as			 no allogeneic blood is available.
Compound 525968: Thiazolidine, 2-hexyl-

Chemical compound data from PubChem database. IUPAC Name: 2-hexyl-1,3-thiazolidine. Molecular Formula: C9H19NS. Molecular Weight: 173.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528658: Pyridoxic acid, 3TMS derivative

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-methyl-3-trimethylsilyloxy-5-(trimethylsilyloxymethyl)pyridine-4-carboxylate. Molecular Formula: C17H33NO4Si3. Molecular Weight: 399.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528692: 1,2,4-Trimethyl-3-Ethylbenzene

Chemical compound data from PubChem database. IUPAC Name: 2-ethyl-1,3,4-trimethylbenzene. Molecular Formula: C11H16. Molecular Weight: 148.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Manchester-Nashua, NH

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Manchester-Nashua, NH metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Manchester-Nashua metro area, New Hampshire, and the U.S. overall.
2017 National Directory of Mental Health Treatment Facilities

The National Directory of Mental Health Treatment Facilities - 2017 is a listing of federal, state, and local government facilities and private facilities that provide mental health treatment services. It includes treatment facilities that responded to the 2016 National Mental Health Services Survey (N-MHSS). The information about each facility that appears in this Directory was provided by that facility in response to the 2016 N-MHSS. The N-MHSS is conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA).The Directory is ordered alphabetically by state, by city within each state, and by facility name within each city. Each facility listing includes codes that represent the services offered and other features of the facility, including codes that indicate services for hearing impaired and non-English-speaking clients. Codes are defined in a key shown on pages v-vii. Because the services offered by a particular facility may change over time, it is always a good idea to verify the information in this Directory when contacting a facility.
Patent AT-E399512-T1: [Translated] TENDON REPLACEMENT IMPLANT

The invention relates to an implant that replaces tendons, especially the interior cruciate ligament of the knee. The inventive implant comprises a first (10) and a second (12) base from spongy and/or cortical and/or cortical/spongy bone material of human or animal origin, linked via a flexible collagen strip (14) and adapted to be fixed in a corresponding implant seat by pressing.
Patent AT-E400607-T1: [Translated] METHOD FOR PRODUCING POLYURETHANE FOAM MOLDED BODY

A method of producing a polyurethane molded article is provided, in which one molding machine which can provide distinctly polyisocyanate component(s) and two kinds of polyol components is used, and prior to completion of the feed of a first polyurethane mixture liquid containing a polyisocyanate and a polyol component without a blowing agent into a mold, a second polyurethane mixture liquid containing a polyisocyanate and a second polyol component with a blowing agent is fed into the mold. The method produces, in a single stage, a polyurethane foam molded article having the skin or high density portion selectively formed on portions of the molded article actually requiring them, where the proportions of the skin and the high density portion and the foamed core can be varied freely.
National Survey on Drug Use and Health (NSDUH-2009)

<p>The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2009 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. In the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.</p>
Patent AT-E399892-T1: [Translated] METHOD FOR PRODUCING A SILICON CARBIDE FIBER WITH A BORON NITRIDE LAYER IN THE FIBER SURFACE

A silicon carbide fiber having a surface boron nitride layer, wherein (a) in a portion of the fiber the concentration of boron increases towards the surface of the fiber and (b) the orientation of the boron nitride layer is parallel to the surface of the fiber.
Diclofenac sodium topical

Diclofenac Sodium 1.5% is a prescription topical solution used to relieve pain and inflammation from conditions like osteoarthritis. It contains diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID) that works by reducing substances in the body that cause pain and swelling. Apply to the affected area as directed by your doctor. Manufactured by SOLA Pharmaceuticals under ANDA204132. This information was generated using AI and is provided for informational and research purposes only.
Compound 530533: 4-Butylbenzoic acid, heptyl ester

Chemical compound data from PubChem database. IUPAC Name: heptyl 4-butylbenzoate. Molecular Formula: C18H28O2. Molecular Weight: 276.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40184-T1: [Translated] ARRANGEMENT IN REMOVABLE OIL FILTERS.

PCT No. PCT/SE85/00252 Sec. 371 Date Feb. 14, 1986 Sec. 102(e) Date Feb. 14, 1986 PCT Filed Jun. 14, 1985 PCT Pub. No. WO86/00373 PCT Pub. Date Jan. 16, 1986.A removable filter container for use with a liquid system, and a method of removing the filter. A first container which houses the filter is removably attached to a main compartment of the liquid system. A second container which is normally empty is attached thereto. A manually operated punching tool connected to the second container punches a hole in the first container to cause liquid to flow from the first container through the punched hole and into the second container, lowering the level of liquid in the first container to prevent overflow of the liquid therein when removing the first container from the liquid system.
Compound 527756: 2,2-Dichloroethyl eicosanoate

Chemical compound data from PubChem database. IUPAC Name: 2,2-dichloroethyl icosanoate. Molecular Formula: C22H42Cl2O2. Molecular Weight: 409.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.